Labcorp Holdings Inc. (LH)
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge?
LH stock surges 25.6% this year, powered by specialty testing expansion, key acquisitions and solid financials.
LH Stock Rises Following the Expansion of Precision Oncology Portfolio
Labcorp expands its precision oncology lineup with new cancer tests and a global diagnostic tool.
Why Is Labcorp (LH) Up 2.5% Since Last Earnings Report?
Labcorp (LH) reported earnings 30 days ago. What's next for the stock?
Are Investors Undervaluing Labcorp (LH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Labcorp (LH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Labcorp (LH) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Buy Labcorp (LH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Labcorp (LH) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Labcorp Holdings Inc. (LH) Q1 2025 Earnings Call Transcript
Labcorp Holdings Inc. (NYSE:LH ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Christin O'Donnell - Investor Relations Adam Schechter - Chairman & Chief Executive Officer Julia Wang - Executive Vice President & Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Ann Hynes - Mizuho Securities Erin Wright - Morgan Stanley Elizabeth Anderson - Evercore ISI Lisa Gill - JPMorgan Jack Meehan - Nephron Research Luke Sergott - Barclays Kevin Caliendo - UBS Michael Ryskin - Bank of America Patrick Donnelly - Citi Eric Coldwell - Baird Kieran Ryan - Deutsche Bank Operator Good day and thank you for standing by. Welcome to the Q1 2025 Labcorp Holdings Earnings Conference Call.
Labcorp (LH) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Labcorp (LH) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Labcorp Q1 Earnings Surpass Estimates, Revenues Miss, Stock Gains
LH delivers better-than-expected earnings in the first quarter of 2025.
Labcorp (LH) Beats Q1 Earnings Estimates
Labcorp (LH) came out with quarterly earnings of $3.84 per share, beating the Zacks Consensus Estimate of $3.73 per share. This compares to earnings of $3.68 per share a year ago.
